VOR · Vor Biopharma Inc
United States · RS rating 68 · As of 2026-11-03
| Price | 19.86 USD |
|---|---|
| 1-day change | +3.2% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 76 / 44 / 38 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 28 / 38 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +77.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +20.9% |
| Market cap (USD) | $714.2M |